Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders
Author:
Publisher
Elsevier
Reference498 articles.
1. Multiple sclerosis and drug discovery: A work of translation;‘t Hart;eBioMedicine (Lancet),2021
2. Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors;Abdel-Maksoud;Molecular Research Review,2019
3. The paradox of cancer genes in non-malignant conditions: Implication for the precision medicine;Adashek;Genome Medicine,2020
4. Therapeutic targeting of repurposed drugs in Alzheimer's disease: Using the multiomics approach;Advani;ACS Omega,2021
5. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach;Advani;Neurochemical International,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor;Brain Research;2024-07
2. Editorial: Molecular targets for anticancer drug discovery and development;Frontiers in Genetics;2024-04-03
3. The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic;Ageing Research Reviews;2024-02
4. Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein;Ageing Research Reviews;2023-12
5. Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms;Food and Chemical Toxicology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3